OTLC

$0.02+8.82%visit website

Oncotelic Therapeutics, Inc.

Market Cap

$8M

Live price × shares (2026-10-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.09

60mo monthly vs SPY

P/E (TTM)

0.0

TTM to Jun 2026 · diluted EPS

P/S (TTM)

117.2

Price / TTM revenue

P/B

0.0

Price / stockholders equity

EV/EBITDA

—

TTM

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue				250
Research & development			0.80	0.35
Total operating expenses	491	2,529	1,853	1,094	5,966
Operating income	(491)	(2,529)	(1,853)	(844)	(5,716)
Interest expense				318
Net income	(1,047)	250,368	(2,194)	388	247,515
EPS (basic) ($)	0.00		0.00	0.00	0.59
EPS (diluted) ($)			0.00	0.00	0.59
Weighted avg. shares (basic)	426,435		443,801	447,387
Weighted avg. shares (diluted)			443,801	467,914

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-01	2026-07-02	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	240.0K	$0.04	$10K	94.12M	View
2026-06-24	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	115.0K	$0.04	$5K	93.88M	View
2026-06-23	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	75.0K	$0.04	$3K	93.77M	View
2026-06-22	2026-06-24	Trieu Vuong	Director & CHAIRMAN AND CEO	Purchase	65.0K	$0.04	$3K	93.69M	View
2026-06-22	2026-06-22	Shah Amit B.	CFO	Purchase	20.0K	$0.05	$1K	378.8K	View

1–5 of 10

1 / 2

Recent News

OTLC 8-K & SEC Filings

Yahoo Finance · 2026-10-27

Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature

Yahoo · 2026-10-26

Oncotelic Keynote to Highlight Partition and Aggregation as a Fundamental Principle for AI Enabled Discovery

Yahoo · 2026-10-20

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Yahoo · 2026-10-05

Oncotelic Therapeutics Inc (OTLC) Stock Price | Live Quotes & Charts | OTCQB

www.timothysykes.com · 2026-09-16

OTLC 8-K & SEC Filings - Yahoo Finance

Yahoo Finanzen Deutschland · 2026-08-04

Oncotelic Therapeutics, Inc. to Present at the OTCQB Virtual Investor Conference on August 6th

Yahoo Finance · 2026-08-03

Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003

Yahoo Finance · 2026-06-29

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

Yahoo Finance · 2026-06-17

Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote

Yahoo Finance · 2026-06-08

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Yahoo Finance · 2026-06-04

What is the current Price Target and Forecast for Oncotelic Therapeutics (OTLC)

Zacks Investment Research · 2023-04-30

Oncotelic Therapeutics Stock Price Forecast. Should You Buy OTLC?

StockInvest.us · 2022-03-27

Oncotelic Therapeutics Inc. Research & Ratings | OTLC

Barron's · 2021-09-15

Oncotelic Therapeutics (OTCPK:OTLC) - Stock Analysis

Simply Wall Street · 2021-04-01

Informational purposes only, not investment advice.

OTLC

Financial Statements

Signals

Factor Profile

Recent News

Oncotelic Therapeutics, Inc. (OTLC)

Reporting Insiders

Factor Profile

Date	Insider	Type	Shares	Value
2026-07-01	Trieu Vuong	P	240,000	$10,344
2026-06-24	Trieu Vuong	P	115,000	$5,175
2026-06-23	Trieu Vuong	P	75,000	$3,375
2026-06-22	Trieu Vuong	P	65,000	$2,925
2026-06-22	Shah Amit B.	P	20,000	$1,000